Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA2A | P29274 | 13/20 | 0.37 |
| ▸ | ADORA3 | P0DMS8 | 10/20 | 0.37 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.32 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.32 |
| ▸ | ADORA1 | P30542 | 3/20 | 0.32 |
| ▸ | ADORA2B | P29275 | 2/20 | 0.31 |
| ▸ | EML4 | Q9HC35 | 1/20 | 0.30 |
| ▸ | ALK | Q9UM73 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL241767 | 0.95 | ADORA2A (0.39) | ADORA2AADORA3ADORA1 | |
| SCHEMBL242740 | 0.95 | ADORA2A (0.39) | ADORA2AADORA3ADORA1 | |
| SCHEMBL243279 | 0.94 | ADORA2A (0.37) | ADORA2AADORA3ADORA1ADORA2B | |
| Trifluoroacetic Acid SCHEMBL294573 | 0.91 | ADORA2A (0.43) | ADORA2AADORA3HRH4HRH3ADORA1 | |
| SCHEMBL242736 | 0.90 | ADORA2A (0.41) | ADORA2AADORA3HRH4HRH3ADORA1 | |
| SCHEMBL291809 | 0.90 | ADORA2A (0.41) | ADORA2AADORA3HRH4HRH3ADORA1 | |
| SCHEMBL243066 | 0.90 | ADORA2A (0.46) | ADORA2AADORA3HRH4HRH3ADORA1 | |
| SCHEMBL239652 | 0.89 | ADORA2A (0.37) | ADORA2AADORA3HRH4HRH3ADORA1 | |
| SCHEMBL242524 | 0.89 | ADORA2A (0.38) | ADORA2AADORA3HRH4HRH3EML4 | |
| SCHEMBL293886 | 0.89 | ADORA2A (0.39) | ADORA2AADORA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2013211-B1 | PURINE DERIVATIVES FOR USE AS ADENOSIN A2A RECEPTOR AGONISTS | NOVARTIS AG (CH) | 2012-03-14 | — | — | EP | disclosed |
| EP-2322525-A1 | Purine derivatives for use as adenosin A2A receptor agonists | Novartis AG (CH) | 2011-05-18 | — | — | EP | disclosed |